Immunotherapy efficacy of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis.

被引：0
|
作者：
Yang, Danrong
Cui, Longgang
Zhang, Yuzi
Zhao, Zhengyi
Bai, Yuezong
机构：
[1] Shanghai Jiao Tong Univ, Dept Resp Med, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21700
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunotherapy efficacy and safety of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in pan-cancer: A systematic review and meta-analysis.
    Duan, Jianchun
    Cui, Longgang
    Wang, Guoqiang
    Zhao, Zhengyi
    Chen, Shiqing
    Song, Jia
    Yang, Lei
    Qi, Chuang
    Fang, Zhili
    Wang, Qing
    Zhang, Yuzi
    Zhao, Jing
    Bai, Yuezong
    Cai, Shangli
    Xiong, Lei
    Wang, Zhijie
    Zhao, Xiaochen
    Wang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
  • [3] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [4] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)
    McLaughlin, Joseph
    Schalper, Kurt A.
    Carvajal-Hausdorf, Daniel E.
    Pelekanou, Vasiliki
    Velcheti, Vamsidhar
    Haack, Herbert
    Silver, Matthew R.
    Herbst, Roy
    LoRusso, Patricia
    Rimm, David L.
    CANCER RESEARCH, 2015, 75
  • [6] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Artem
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2016, 96 : 467A - 467A
  • [7] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Arteni
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    MODERN PATHOLOGY, 2016, 29 : 467A - 467A
  • [8] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [9] Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer
    Jove, Maria
    Vilarino, Noelia
    Nadal, Ernest
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S364 - S368
  • [10] Programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC), results of a single institution
    Slezak, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S112 - S112
12345